Articles from Chimerix, Inc.; Jazz Pharmaceuticals plc
Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio
-Dordaviprone addresses a significant unmet patient need for patients with rare, high-grade brain tumors-
By Chimerix, Inc.; Jazz Pharmaceuticals plc · Via GlobeNewswire · March 5, 2025